PRINCETON, N.J.–(BUSINESS WIRE)–#CitiusTech—CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, today announced its inclusion as Horizon 3 Market Leader in the recently published HFS Horizons: HCP Service Providers, 2024 report. This distinguished position affirms CitiusTech’s integral role in addressing global delivery challenges faced by Healthcare Providers, with exceptional performance across primary care, acute care, post-acute, and rehabilitation services.
The HFS Horizons report meticulously examines the capabilities of 36 service providers. It focuses on their ability to alleviate the ongoing deterioration of the triple aim of care—reducing costs, enhancing care experiences, and improving health outcomes. The report identifies critical factors such as clinician shortages, an aging population, the prevalence of chronic diseases, and inefficient payment mechanisms that exacerbate the challenges faced by healthcare systems worldwide.
Rohan Kulkarni, Executive Research Leader – Healthcare and Life Sciences Research, HFS Research, said, “It is incumbent on all the stakeholders in the healthcare ecosystem to positively impact the triple aim of care, to reduce the cost of care, enhance the experience of care, and improve health outcomes. CitiusTech has shown the ability to do that with growing consistency driving confidence to sustain its performance across the horizon.”
Amid these challenges, the report highlights a promising future driven by technological advancements, innovative care delivery models, and strategic partnerships. Service providers like CitiusTech stand at the forefront of this transformation, transcending traditional transactional processes and pioneering clinical innovations that optimize care across the healthcare ecosystem.
“At CitiusTech, we understand the seismic shifts in the Healthcare Providers landscape towards value-based care. Patient satisfaction is now fundamental to financial success,” said John Squeo, Senior Vice President – Healthcare Provider Market, CitiusTech. “By leveraging our deep clinical and technical expertise, we are empowering Providers with innovative solutions that transform patient experiences into personalized and meaningful interactions. Our investments in GenAI and patient experience platforms such as Salesforce address accessibility issues, while data analytics and AI optimize workflows and decision-making. Recognizing the persistent challenges of documentation burden and workforce strain, we prioritize intelligent automation to balance efficiency with the necessary human oversight, ensuring quality and safety. CitiusTech’s dedication to client engagement and excellence has boosted patient satisfaction, sped up development, and saved operational costs for Healthcare Providers.”
CitiusTech’s strengths noted in the report include:
From 2020 to 2023, CitiusTech has strategically expanded through key acquisitions, including Wilco Source (2022) and Fluid Edge Consulting (2020). The company has also formed partnerships with industry leaders such as MS Azure, AWS, Google, Salesforce, Snowflake, Databricks, UiPath and others. CitiusTech’s flagship IP includes Re-imaGen AI, PERFORM+ DataScale, RealSight Price Transparency, and a provider performance measure product, all designed to enhance healthcare outcomes and operational efficiencies.
To download the full report, please click here.
About CitiusTech
CitiusTech is a leading provider of digital technology and consulting services to payer, provider, medical technology, and life sciences companies. With over 8,500 healthcare technology professionals worldwide, CitiusTech powers healthcare digital innovation, business transformation and industry-wide convergence for over 140 organizations, through next-generation technologies, solutions, and products. Key focus areas include healthcare interoperability, secure data management, quality and performance analytics, real world data, clinical research optimization, virtual trials, value-based care, patient experience, medical imaging, connected health, payer-provider convergence, care coordination and population health management. CitiusTech’s cutting-edge technology expertise, deep healthcare domain expertise and a strong focus on digital transformation enables healthcare and life sciences companies to reinvent themselves to deliver better outcomes, accelerate growth, drive efficiencies, and ultimately make a meaningful impact to patients. Follow CitiusTech on Twitter or LinkedIn.
Contacts
Saviera Barretto Saviera.Barretto@citiustech.com
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…
SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…